The Global Western Blotting Market size was valued USD 600 Million in 2021 and is expected to rise to USD 860 Million by 2028 at a CAGR of 5.2%.
The global western blotting market size is projected to grow at a CAGR of 5.2% during the forecast period. The global market generated a revenue of over $600 Million in 2021 and is anticipated to reach a market value of $860 Million by 2028. The report analyzes the global western blotting market’s drivers, restraints/challenges, and the effect they have on the demands during the projection period. In addition, the report explores emerging opportunities in the western blotting market.
The western blotting technique is extensively used in cell and molecular biology. With the help of this technique, researchers can identify a single protein from a mixture of complex proteins that are extracted from cells. There are 3 elements used in western blotting. The first step involves the separation of proteins based on size, followed by transferring of separated proteins to a solid support, and the last step involves marking the target protein with the help of primary & secondary antibodies.
In the last step, the primary antibody is generally either animal-derived or created synthetically, and is able to recognize and bind with the target protein. A solution containing the primary antibody is used to wash off the electrophoresis membrane. The secondary antibody that is visualized by either staining, radioactivity, or by immunofluorescence methods, then identifies and attaches itself to the primary antibody. The whole process allows for full-proof detection of the desired protein.
The global western blotting market has extensive use in biochemistry. More than 10% of publications based on proteins use the white blotting method and various software tools are used for the processing and alignment of the image captured for proper presentation of white blotting results.
The global market showed a mixed reaction to Covid-19. On one side the revenue in the global market declined due to transport restrictions, shortage of raw materials, and closure of manufacturing units. However, the demand for white blotting technology increased for the extensive research conducted globally to understand the virus and come up with solutions to tackle it. Once the restrictions were lifted, the manufacturing units scaled up their products and since then the global market has witnessed immense growth.
The global western blotting market generates huge revenues because of western blotting’s application in the detection and diagnosis of HIV. The confirmatory test involves the employment of western blots to detect anti-HIV in the given human serum sample. The number of reported HIV medical cases has increased drastically in the last couple of years. More than 37 million of the world population was diagnosed with HIV in 2020 while the number of patients in 2010 was around 3 million. Another reason for the growth in HIV diagnostic tests is the rise in blood donations across the globe. The donated blood can only be safely used once it has passed the necessary tests, one of which is a test for HIV detection. This is anticipated to aid the global market growth in the coming years.
Western blotting tests are used as definitive tests that are conducted to confirm vCJD or commonly known as mad cow disease which spreads due to the consumption of beef that suffers from bovine spongiform encephalopathy. The growth in meat consumption and beef being a part of the staple diet in many nations has resulted in the increase in medical cases related to variant Creutzfeldt–Jakob disease thus propelling global market expansion.
Working on western blotting technology requires extremely skilled professionals owing to the detailed, microscopic, and thorough nature of the technology. Since the results of these tests have strong implications on the medical data of patients, there is no room for error thus making a high degree of experimental optimization a necessity. Since there is a dearth of skilled professionals as compared to the rising demand and adoption of western blotting technology, the global market is expected to be restrained during the forecast period. This is also coupled with technological advancements in the global market like the launching of AlphaScreen technology which eliminates the washing steps thus becoming more time-efficient. However, there are not enough technicians capable of handling such advanced technology with accuracy and great efficiency.
Since we are currently at a stage where automation is increasingly being adopted in almost all fields, the global western blotting market has also witnessed a rise in automating many white blotting processes. There is a huge jump registered in software used for imaging results of western blotting. With the rising number of western blot tests, there is a growth in the subsequent data generated that is highly sensitive and needs technically rich systems to document these data. The systems provide for processing, organizing, and interpreting the collected data. Currently, due to the high cost of automated systems, the traditional western blotting technique is more in demand. However, if the cost factor can be reduced, the global market has higher growth opportunities in terms of automated processes.
Even though the white blotting technique has high use in molecular biology along with huge applications in research, the developmental life cycle of white blots is extremely complex rendering it difficult to be produced by small to medium-scale manufacturers. Domestic players with insufficient funds may not find it cost-effective thus making the global market lose potential consumers. A rise in the shift towards other technologies like RIBA or ELISA is witnessed in many countries which may pose a challenge for global market growth.
By application, the global market segments are clinical diagnostics, agriculture, and biomedical, and is anticipated to be dominated by the rising application in the biomedical segment. This is owed to the increased funding received from government agencies especially on proteomics research along with the rising need for white blogs in the pharmaceutical sector during the drug development process.
By product, the global market is segmented into instruments and consumables. The instrument segment is divided into electrophoresis, imager (fluorescent), and blotting systems. The consumables segment is showing healthy signs of high global market growth because of the rise in diseases that require white blotting technology for detection. The blotting system may also register high revenue because of its properties like high efficiency and sensitivity along with lesser run time.
By end-user, hospital, research institute, and biopharma are the global market segments. Research institutes may lead the global market during the projection period.
The global western blotting market generates the highest revenue from North America since the USA is the hub of western blotting technology. The trend is expected to continue in the coming years mainly due to the highly advanced medical diagnostic and biotechnical sector in the region. As per reports submitted by the USDA, the adoption of western blotting in agriculture biotechnology is anticipated to aid regional growth.
Asia-Pacific and Europe are also showing excellent signs of steady growth in the coming years mainly due to the exponential rise in the pharmaceutical industry in these regions. As per the Government of China, the total revenue in pharmaceutical and dietary segments was over $120 Billion in 2018 and has only grown since then.
The global western blotting market is dominated by players like EMD Millipore Corporation, Bio-Rad Laboratories, Perkin Elmer Inc., LI-COR Inc., Advansta Inc., GE Healthcare, Thermo Fisher Scientific Inc., and Danaher Corporation.
By Application
By Product
By End-User
FrequentlyAsked Questions
The global western blotting market generates huge revenues because of western blotting’s application in the detection and diagnosis of HIV. Western blotting tests are used as definitive tests conducted to confirm vCJD or commonly known as mad cow disease which spreads due to the consumption of beef that suffers from bovine spongiform encephalopathy. The growth in meat consumption where beef is a part of the staple diet in many nations has resulted in the increase in medical cases related to variant Creutzfeldt–Jakob disease thus propelling global market expansion.
As per Zion Market Research, the global western blotting market is projected to grow at a CAGR of 5.2% during the forecast period. The global market generated a revenue of over $600 Million in 2021 and is projected to reach a market value of $860 Million by 2028.
The global western blotting market generates the highest revenue from North America since the USA is the hub of western blotting technology. The trend is expected to continue in the coming years mainly due to the highly advanced medical diagnostic and biotechnical sector in the region. As per reports submitted by the USDA, the adoption of western blotting in agriculture biotechnology is anticipated to aid regional growth.
The global western blotting market is dominated by players like EMD Millipore Corporation, Bio-Rad Laboratories, Perkin Elmer Inc., LI-COR Inc., Advansta Inc., GE Healthcare, Thermo Fisher Scientific Inc., and Danaher Corporation.
RelatedNews
HappyClients
Zion Market Research
Tel: +1 (302) 444-0166
USA/Canada Toll Free No.+1 (855) 465-4651
3rd Floor,
Mrunal Paradise, Opp Maharaja Hotel,
Pimple Gurav, Pune 411061,
Maharashtra, India
Phone No +91 7768 006 007, +91 7768 006 008
US OFFICE NO +1 (302) 444-0166
US/CAN TOLL FREE +1 (855) 465-4651
Email: sales@zionmarketresearch.com
We have secured system to process your transaction.
Our support available to help you 24 hours a day, five days a week.
Monday - Friday: 9AM - 6PM
Saturday - Sunday: Closed